OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
23
Results
Show all
Save search
Copy query
Show results for
Unknown
(23)
Publication Date
Release Date
2010
(4)
2015
(3)
2011
(3)
2024
(2)
2022
(2)
2017
(2)
2026
(1)
2023
(1)
2021
(1)
2020
(1)
2016
(1)
2013
(1)
2008
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Low-bias phosphopeptide enrichment from scarce samples using plastic antibodies.
Not available
S-EPMC4486973
|
biostudies-literature
Cite
Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose).
Not available
S-EPMC5129796
|
biostudies-literature
Cite
Comprehensive blood metabolomics profiling of Parkinson's disease reveals coordinated alterations in xanthine metabolism.
Not available
S-EPMC10951366
|
biostudies-literature
Cite
Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson's study.
Not available
S-EPMC10667262
|
biostudies-literature
Cite
Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia.
Not available
S-EPMC11490412
|
biostudies-literature
Cite
Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions.
Not available
S-EPMC7285525
|
biostudies-literature
Cite
Intravitreal aflibercept 8 mg in patients from Japan with diabetic macular edema: 48-week subgroup analysis of the PHOTON trial.
Not available
S-EPMC12948817
|
biostudies-literature
Cite
Results of the two incidence screenings in the National Lung Screening Trial.
Not available
S-EPMC4307922
|
biostudies-literature
Cite
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Not available
S-EPMC4356534
|
biostudies-literature
Cite
The National Lung Screening Trial: overview and study design.
Not available
S-EPMC3009383
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets